NCT06555614View on ClinicalTrials.gov

Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

June 13, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

February 28, 2027

Conditions
Breast Cancer FemaleBreast Reconstruction
Interventions
OTHER

Acellular Dermal Matrix(ADM)

A comparison of the short-term complications associated with acellular dermal matrix in the test group and the control group.

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

DOF Inc.
All Listed Sponsors
lead

DOF Inc.

INDUSTRY

NCT06555614 - Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction | Biotech Hunter | Biotech Hunter